The Ideal Diet A phase 3 double-blinded, randomized clinical control trial published in 2022 that looked at the use of a GLP-1 agonist, Tirzepatide (Mounjaro ), for the treatment of obesity has paved the way for the use of GLP-1 agonists for weight loss (1)
liraglutide (Victoza, Saxenda)
In this article, well discover how a single new drug not only revolutionized a companys fortunes but also an entire landscape
Reviews from real Noom users Leveraging Nooms personalized programs for weight maintenance Youve already worked on your diet and exercise routines, but staying on track after stopping Ozempic or Wegovy requires ongoing support and focus
Revisiting the oxidation of flavonoids: loss, conservation or enhancement of their antioxidant properties
GLP-1 injections, also known as Glucagon-like peptide-1 receptor agonists, are a type of medication that we utilize in our medical practice to target the symptoms of type 2 diabetes